You are here

Clinical Trials: Eye Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, October 23, 2015 - 12:00
Conditions:   Dry Macular Degeneration;   Geographic Atrophy
Intervention:   Biological: CPCB-RPE1
Sponsor:   Regenerative Patch Technologies, LLC
Recruiting - verified January 2016
Posted: Wednesday, June 10, 2015 - 12:00
Condition:   Uveitis
Intervention:   Other: intravitreous administration of regulator T-cells
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Posted: Monday, May 18, 2015 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Drug: hRPC
Sponsor:   ReNeuron Limited
Recruiting - verified December 2015
Posted: Wednesday, December 31, 2014 - 12:00
Conditions:   Retinal Degeneration;   Primary Open-angle Glaucoma
Interventions:   Procedure: Intravitreal transplantation of mesenchymal stem cell;   Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells
Sponsors:   University of Sao Paulo;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified December 2014
Posted: Tuesday, December 16, 2014 - 12:00
Condition:   Retinitis Pigmentosa (RP)
Intervention:   Biological: human retinal progenitor cells
Sponsor:   jCyte, Inc
Recruiting - verified March 2016
Posted: Monday, November 24, 2014 - 12:00
Conditions:   Cervical Spinal Cord Injury;   Spine Injury;   Spinal Cord Trauma
Intervention:   Biological: AST-OPC1
Sponsor:   Asterias Biotherapeutics, Inc.
Recruiting - verified May 2016
Posted: Sunday, November 2, 2014 - 11:00
Condition:   Age-related Macular Degeneration
Intervention:   Biological: OpRegen
Sponsor:   Cell Cure Neurosciences Ltd.
Recruiting - verified February 2016
Posted: Wednesday, October 22, 2014 - 12:00
Condition:   Retinitis Pigmentosa
Interventions:   Biological: Intravitreal injection of Autologous bone marrow Stem Cell;   Other: Subconjunctival injection of saline
Sponsors:   Red de Terapia Celular;   Spanish National Health System;   Hospital Universitario Virgen de la Arrixaca;   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia;   Public Health Service, Murcia;   Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Recruiting - verified September 2015
Posted: Monday, May 19, 2014 - 12:00
Conditions:   Corneal Disease;   Pterygium;   Myopia;   Hyperopia
Interventions:   Procedure: LSCs and amniotic membrane (Modified Technique);   Procedure: Amniotic membrane only (Traditional Technique);   Procedure: PRK, LSCs, and amniotic membrane (Modified Technique);   Procedure: PRK only (Traditional Technique);   Drug: Levofloxacin;   Drug: Betamethasone;   Drug: Limbal stem cells (LSCs)
Sponsor:   Sun Yat-sen University
Recruiting - verified May 2014
Posted: Tuesday, April 1, 2014 - 12:00
Condition:   Myopic Macular Degeneration
Intervention:   Biological: MA09-hRPE Cellular Therapy
Sponsors:   University of California, Los Angeles;   Ocata Therapeutics
Recruiting - verified February 2016

Pages